6185 • HKG
Cansino Biologics Inc
$81.30
Jun 30, 11:42:24 AM GMT+8 · HKD · HKG · Disclaimer
StockHK listed securityCN headquartered
Previous close
$81.25
Day range
$80.50 - $83.20
Year range
$66.70 - $430.00
Market cap
36.92B HKD
Avg Volume
2.79M
P/E ratio
8.96
Dividend yield
-
Primary exchange
HKG
Market news
Financials
Income Statement
Financial performance
Revenue
Net income
(CNY)Mar 2022Y/Y change
Revenue
499.36M6.98%
Operating expense
237.90M-18.33%
Net income
121.41M960.23%
Earnings per share
EBITDA
128.96M394.02%
Effective tax rate
5.46%
Financial performance
Total assets
Total liabilities
(CNY)Mar 2022Y/Y change
Cash and short-term investments
7.12B41.11%
Total assets
11.93B58.63%
Total liabilities
3.35B138.08%
Total equity
8.58B
Shares outstanding
247.12M
Price to book
2.50
Return on assets
2.37%
Return on capital
2.82%
Financial performance
Net change in cash
(CNY)Mar 2022Y/Y change
Net income
121.41M960.23%
Cash from operations
-598.15M-4,717.56%
Cash from investing
-894.01M-11,145.34%
Cash from financing
22.72M-90.05%
Net change in cash
-1.48B-737.69%
Free cash flow
-791.59M-79.69%
About
CanSino Biologics, often abbreviated as CanSinoBIO, is a Chinese vaccine company. Wikipedia
Founded
Jan 13, 2009
Headquarters
Employees
1,946
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for